Resistance to an irreversible epidermal growth factor receptor ( EGFR ) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies .2992 ) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2 / neu .Dacomitinib com ......